ABVC BioPharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards
ABVC BioPharma, Inc. (ABVC) had Deferred Tax Assets, Operating Loss Carryforwards of $6.81 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-08-12
- 2026-06-30: Deferred Tax Assets, Operating Loss Carryforwards $6.81M.
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $6.62M.
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.47M.
- 2025-09-30: Deferred Tax Assets, Operating Loss Carryforwards $6.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-06-30 | $6.81M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $6.62M 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $6.47M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $6.00M 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | $6.05M 10-Q · filed 2025-08-13 | |
| 2024-12-31 | $5.68M 10-Q/A · filed 2026-03-03 | |
| 2015-12-31 | $75.69K 10-Q · filed 2016-02-23 | |
| 2015-09-30 | $85.52K 10-K · filed 2015-11-27 | |
| 2015-06-30 | $24.65K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $25.90K 10-Q · filed 2015-06-05 | |
| 2014-12-31 | $25.06K 10-Q · filed 2016-02-23 | |
| 2014-09-30 | $23.23K 10-K · filed 2015-11-27 | $24.03K 10-K · filed 2015-04-17 |
| 2013-12-31 | $0.00 10-Q · filed 2015-04-17 | |
| 2013-09-30 | $0.00 10-K · filed 2015-04-17 | $5.76M 10-K · filed 2015-04-16 |
| 2012-09-30 | $5.54M 10-K · filed 2015-04-16 | |
| 2011-09-30 | $4.47M 10-K · filed 2015-04-15 |